• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿扎丙宗在滑膜组织和滑液中的浓度。

Concentration of azapropazone in synovial tissues and fluid.

作者信息

Spahn H, Thabe K, Mutschler E, Tillmann K, Gikalov I

出版信息

Eur J Clin Pharmacol. 1987;32(3):303-7. doi: 10.1007/BF00607579.

DOI:10.1007/BF00607579
PMID:3595703
Abstract

The concentration-time curves of azapropazone in synovial fluid and tissues have been studied in arthritic patients after an i.v. bolus (600 mg) and under steady-state conditions. Synovial fluid and tissue samples were taken intraoperatively 0.45-60 h after administration. The azapropazone concentrations in synovial fluid, synovial tissue and plasma were correlated. The levels in synovial fluid were usually lower than corresponding plasma levels. Under steady-state conditions azapropazone did not accumulate in synovial tissues.

摘要

已对关节炎患者静脉推注(600毫克)后及稳态条件下阿扎丙宗在滑液和组织中的浓度-时间曲线进行了研究。给药后0.45至60小时在手术中采集滑液和组织样本。滑液、滑膜组织和血浆中的阿扎丙宗浓度具有相关性。滑液中的水平通常低于相应的血浆水平。在稳态条件下,阿扎丙宗不会在滑膜组织中蓄积。

相似文献

1
Concentration of azapropazone in synovial tissues and fluid.阿扎丙宗在滑膜组织和滑液中的浓度。
Eur J Clin Pharmacol. 1987;32(3):303-7. doi: 10.1007/BF00607579.
2
Pharmacokinetics of azapropazone following single oral and intravenous doses.
Arzneimittelforschung. 1979;29(6):971-2.
3
Pharmacokinetics of azapropazone in the elderly.阿扎丙宗在老年人中的药代动力学。
Br J Clin Pharmacol. 1982 Jul;14(1):116-9. doi: 10.1111/j.1365-2125.1982.tb04947.x.
4
Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.关节炎患者血浆和滑液中布洛芬的动力学
J Clin Pharmacol. 1986 Jan;26(1):65-70. doi: 10.1002/j.1552-4604.1986.tb02905.x.
5
[Synovial tissue levels in comparison with synovial fluid and serum concentrations following a single daily administration of 20 mg piroxicam (Felden)].[每日单次服用20毫克吡罗昔康(费啶)后,滑膜组织水平与滑液及血清浓度的比较]
Z Rheumatol. 1986 Sep-Oct;45(5):271-6.
6
Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.氟比洛芬在类风湿性关节炎中的血浆及滑液动力学
Br J Clin Pharmacol. 1986 Feb;21(2):155-63. doi: 10.1111/j.1365-2125.1986.tb05170.x.
7
[Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].不同静脉注射剂量阿扎丙宗的人体药代动力学(高效液相色谱法测定)(作者译)
Arzneimittelforschung. 1982;32(4):423-6.
8
[Azapropazone plasma levels under simultaneous treatment with an antacid or laxative].
Arzneimittelforschung. 1977;27(12):2411-4.
9
Evaluation of surfactant proteins A, B, C, and D in articular cartilage, synovial membrane and synovial fluid of healthy as well as patients with osteoarthritis and rheumatoid arthritis.评估健康人群以及骨关节炎和类风湿关节炎患者的关节软骨、滑膜和滑液中的表面活性剂蛋白 A、B、C 和 D。
PLoS One. 2018 Sep 20;13(9):e0203502. doi: 10.1371/journal.pone.0203502. eCollection 2018.
10
Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.类风湿关节炎患者血浆及滑液中柳氮磺胺吡啶及其两种代谢产物的浓度
Rheumatol Int. 1985;5(6):247-51. doi: 10.1007/BF00541351.

引用本文的文献

1
Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.非甾体抗炎药在滑液中的药代动力学
Clin Pharmacokinet. 1999 Mar;36(3):191-210. doi: 10.2165/00003088-199936030-00002.
2
Effects of azapropazone on pain-related brain activity in human subjects.阿扎丙宗对人类受试者疼痛相关脑活动的影响。
Br J Clin Pharmacol. 1995 Dec;40(6):545-52. doi: 10.1111/j.1365-2125.1995.tb05799.x.
3
Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures.

本文引用的文献

1
Transsynovial distribution of ibuprofen in arthritic patients.布洛芬在关节炎患者中的滑膜分布情况。
Clin Pharmacol Ther. 1981 Apr;29(4):487-92. doi: 10.1038/clpt.1981.67.
2
Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages.在培养的巨噬细胞中抗炎药物对前列腺素生成的抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 1981 Jan;315(3):269-76. doi: 10.1007/BF00499844.
3
[Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].不同静脉注射剂量阿扎丙宗的人体药代动力学(高效液相色谱法测定)(作者译)
某些抗关节炎药物对大鼠软骨肉瘤培养物中Ⅱ型胶原蛋白和糖胺聚糖合成的影响。
Agents Actions. 1994 May;41(3-4):193-9. doi: 10.1007/BF02001916.
4
Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.非甾体抗炎药在滑液中的药代动力学最新研究成果。
Clin Pharmacokinet. 1989 Sep;17(3):145-62. doi: 10.2165/00003088-198917030-00002.
5
Excretion of azapropazone in human breast milk.阿扎丙宗在人母乳中的排泄情况。
Eur J Clin Pharmacol. 1990;39(3):271-3. doi: 10.1007/BF00315109.
6
Tenoxicam concentrations in synovium and joint cartilage in humans.人体滑膜和关节软骨中的替诺昔康浓度。
Agents Actions. 1991 Mar;32(3-4):295-8. doi: 10.1007/BF01980889.
7
A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.非甾体抗炎药的滑液浓度与其体外活性的比较。
Agents Actions. 1991 Mar;32(3-4):261-5. doi: 10.1007/BF01980883.
Arzneimittelforschung. 1982;32(4):423-6.
4
[Transsynovial kinetics and correlation of dosage and effect of non-steroidal anti-rheumatic agents].[非甾体类抗风湿药的经滑膜动力学及剂量与效应的相关性]
Fortschr Med. 1982 Sep 23;100(36):1642-6.
5
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.人体滑液和滑膜组织中的抗风湿药物浓度。关于血管外药代动力学的观察。
Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002.
6
The action of azapropazone, oxyphenbutazone and phenylbutazone on lysosomes.阿扎丙宗、羟基保泰松和保泰松对溶酶体的作用。
J Pharm Pharmacol. 1971 Dec;23(12):931-5. doi: 10.1111/j.2042-7158.1971.tb09895.x.
7
Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation.人滑膜对血浆蛋白的通透性。与分子大小及炎症的关系。
Arthritis Rheum. 1971 Sep-Oct;14(5):560-70. doi: 10.1002/art.1780140503.
8
Naproxen concentrations in serum, synovial fluid, and synovium.
Scand J Rheumatol. 1977;6(3):155-7. doi: 10.3109/03009747709095441.
9
Investigation of phenylbutazone in synovial fluid.滑液中保泰松的研究。
J Int Med Res. 1977;5 Suppl 2:26-9.
10
[On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].
Arzneimittelforschung. 1977;27(9):1713-5.